Roche Wins Genentech, But Will Biotech Employees Remain?
This article was originally published in The Pink Sheet Daily
Executive Summary
With a sweetened bid, the Swiss pharma gains the blessing of Genentech’s special committee, but whether the innovator’s valuable staffers sanction the union is an open question.
You may also be interested in...
California Hangs On To Its Biotech Crown, But Other States Are Luring Some Jobs
Should I stay or should I go? A new survey suggests many top execs think manufacturing and R&D are better off out-of-state.
California Hangs On To Its Biotech Crown, But Other States Are Luring Some Jobs
Should I stay or should I go? A new survey suggests many top execs think manufacturing and R&D are better off out-of-state.
Blinding Them With Science: Genentech Tries To Win Shareholders Over
Genentech's March 2 presentation to analysts and investors - a four hour plus love-in dominated by talk of peptides and pathways - seems to have worked